Mates Sharon's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Mar 13, 2023
- Accession no.
- 0001209191-23-018283
- Filed
- Mar 13, 2023
- Trade date
- Mar 9-13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.73M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mates SharonCIK 0001585699 | Director, Officer (Chairman, President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | Common Stock | AGrant or awardAcquired | +41,770 | $0.00 | $0 | 1,172,079 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −34,965 | $43.28 | −$1,513,285.2 | 1,137,114 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −6,805 | $42.51 | −$289,280.55 | 1,130,309 | Direct | |
| Mar 10, 2023 | Common Stock | MOption exerciseAcquired | +20,565 | – | – | 1,150,874 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −19,153 | $45.06 | −$863,034.18 | 1,131,721 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −1,412 | $44.08 | −$62,240.96 | 1,130,309 | Direct | |
| Mar 13, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $3.26 | +$65,200 | 1,150,309 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | Common Stock | MOption exerciseDisposed | −20,565 | $0.00 | $0 | 41,131 | Direct | |
| Mar 13, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.